02 oct 25   medpal ai plc - result of wrap retail offer medpal ai plc | mpal | 8.8 0.25 2.9% | mkt cap: 36.1m    rns number : 8079b medpal ai plc 02 october 2025   not for release, publication or distribution, directly or indirectly, in whole or in part, or into or within the united states, australia, new zealand, canada, south africa or japan, or any member state of the eea, or any other jurisdiction where, or to any other person to whom, to do so might constitute a violation or breach of any applicable law or regulation. please see the important notice at the end of this announcement.   2 october 2025   medpal ai plc ("medpal ai" or the "company")   result of placing and wrap retail offer   further to its announcements made on 1 october 2025 (the "launch announcements"), medpal ai plc is pleased to announce the successful completion of the placing and wrap retail offer (together, the "fundraise"), at the issue price of 8 pence per share. the fundraise has raised, in aggregate, gross proceeds of approximately £545,304 comprising  £400,000 pursuant to the placing and £145,304 pursuant to the wrap retail offer. accordingly, the company will issue 6,816,305 new ordinary shares ("new ordinary shares") to investors in the fundraise. the proceeds of the fundraise will be  used to progress the company's strategy with regard to the recently announced acquisition of assets from universal pharmacy ltd (in administration), which will enable medpal ai to establish itself in the rapidly growing glp-1 agonist market for obesity treatment, including drugs such as semaglutide (eg. ozempic and mounjaro).   settlement of the new ordinary shares and admission are expected to take place on or around 8.00 a.m. on 8 october 2025. the fundraise is conditional upon, among other things, admission (as defined below) becoming effective.   admission and total voting rights application has been made for the 6,816,305  new ordinary shares to be admitted to trading on aim on or around 8 october 2025 ("admission"). the new ordinary shares will rank pari passu with the ordinary shares of the company in issue. following admission, the company's issued share capital will comprise 419,899,640 ordinary shares of 0.02p each, with each share carrying the right to one vote, therefore the total number of voting rights in the company will be 419,899,640. this figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the company, or a change to their interest in the company, under the financial conduct authority's disclosure guidance and transparency rules.   capitalised terms used in this announcement have the meanings given to them in the launch announcements, unless the context provides otherwise.   this announcement contains inside information for the purposes of article 7 of eu regulation 596/2014 (which forms part of domestic uk law pursuant to the european union (withdrawal) act 2018). the directors of the company are responsible for the contents of this announcement.       medpal ai plc jason drummond     www.medpalplc.com cairn financial advisers llp louise o'driscoll/jo turner   +44 20 7213 0880 clear capital markets limited bob roberts     +44(0) 20 3869 6080       winterflood retail access platform sophia bechev, kaitlan billings wrap@winterflood.com +44(0) 20 3100 0214     further information on the company can be found on its website at www.medpalplc.com                 this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   roimtbrtmtmmmba return to news summary

Label: Gestiegen